These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 10946777)

  • 1. Shorter waiting times for hepatitis C virus seropositive recipients of cadaveric renal allografts from hepatitis C virus seropositive donors.
    Mandal AK; Kraus ES; Samaniego M; Rai R; Humphreys SL; Ratner LE; Maley WR; Burdick JF
    Clin Transplant; 2000 Aug; 14(4 Pt 2):391-6. PubMed ID: 10946777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of kidneys from hepatitis C seropositive donors shortens waitlist time but does not alter one-yr outcome.
    Woodside KJ; Ishihara K; Theisen JE; Early MG; Covert LG; Hunter GC; Gugliuzza KK; Daller JA
    Clin Transplant; 2003 Oct; 17(5):433-7. PubMed ID: 14703926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality and Kidney Transplantation Outcomes Among Hepatitis C Virus-Seropositive Maintenance Dialysis Patients: A Retrospective Cohort Study.
    Sawinski D; Forde KA; Lo Re V; Goldberg DS; Cohen JB; Locke JE; Bloom RD; Brensinger C; Weldon J; Shults J; Reese PP
    Am J Kidney Dis; 2019 Jun; 73(6):815-826. PubMed ID: 30704882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kidney transplantation from hepatitis C virus-positive donors into hepatitis C virus-positive recipients: a safe way to expand the donor pool?
    Veroux P; Veroux M; Puliatti C; Cappello D; Macarone M; Gagliano M; Fiamingo P; Di Mare M; Spataro M; Ginevra N
    Transplant Proc; 2005; 37(6):2571-3. PubMed ID: 16182747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Hepatitis C Virus Antibody-Positive Donor Livers in Hepatitis C Nonviremic Liver Transplant Recipients.
    Luckett K; Kaiser TE; Bari K; Safdar K; Schoech MR; Apewokin S; Diwan TS; Cuffy MC; Anwar N; Shah SA
    J Am Coll Surg; 2019 Apr; 228(4):560-567. PubMed ID: 30586641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal transplantation from seropositive hepatitis C virus donors to seronegative recipients in Spain: a prospective study.
    Franco A; Moreso F; Merino E; Sancho A; Kanter J; Gimeno A; Balibrea N; Rodriguez M; Perez Contreras F
    Transpl Int; 2019 Jul; 32(7):710-716. PubMed ID: 30773693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The long-term outcomes of hepatitis C virus core antigen-positive Japanese renal allograft recipients.
    Okino K; Okushi Y; Mukai K; Matsui Y; Hayashi N; Fujimoto K; Adachi H; Yamaya H; Yokoyama H
    Clin Exp Nephrol; 2017 Dec; 21(6):1113-1123. PubMed ID: 28357506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of hepatitis C virus infection among organ transplant recipients: implications for policies on organ procurement.
    Bouthot BA; Murthy BV; Schmid CH; Levey AS; Pereira BJ
    Transplantation; 1997 Mar; 63(6):849-53. PubMed ID: 9089225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts.
    Khapra AP; Agarwal K; Fiel MI; Kontorinis N; Hossain S; Emre S; Schiano TD
    Liver Transpl; 2006 Oct; 12(10):1496-503. PubMed ID: 16964597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shorter waitlist times and improved graft survivals are observed in patients who accept hepatitis C virus+ renal allografts.
    Scalea JR; Barth RN; Munivenkatappa R; Philosophe B; Cooper M; Whitlow V; LaMattina JC
    Transplantation; 2015 Jun; 99(6):1192-6. PubMed ID: 25340605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of hepatitis C virus infection among cadaver organ donors: evidence for low transmission of disease.
    Roth D; Fernandez JA; Babischkin S; De Mattos A; Buck BE; Quan S; Olson L; Burke GW; Nery JR; Esquenazi V
    Ann Intern Med; 1992 Sep; 117(6):470-5. PubMed ID: 1323944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of hepatitis C virus infection on patient and graft survival in kidney transplantation.
    Manga Sahin G; Sahin S; Kantarci G; Ergin H
    Transplant Proc; 2006 Mar; 38(2):499-501. PubMed ID: 16549159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A controlled study of hepatitis C transmission by organ transplantation. The New England Organ Bank Hepatitis C Study Group.
    Pereira BJ; Wright TL; Schmid CH; Levey AS
    Lancet; 1995 Feb; 345(8948):484-7. PubMed ID: 7532254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver transplantation from anti-hepatitis C virus-positive donors: our experience.
    Álvaro E; Abradelo M; Fuertes A; Manrique A; Colina F; Alegre C; Calvo J; García M; García-Sesma A; Cambra F; Sanabria R; Moreno E; Jimenez C
    Transplant Proc; 2012; 44(6):1475-8. PubMed ID: 22841188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kidney transplantation from donors with viral B and C hepatitis.
    Veroux P; Veroux M; Sparacino V; Giuffrida G; Puliatti C; Macarone M; Fiamingo P; Cappello D; Gagliano M; Spataro M; Di Mare M; Cannizzaro MA; Severino V
    Transplant Proc; 2006 May; 38(4):996-8. PubMed ID: 16757242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatitis C viruses antibodies. Prevalence and their influence on morbidity-mortality in renal transplant recipients, in the last two years of the kidney transplantation program in La Plata city].
    Curciarello JO; Adrover RE; Chiera AO; Touceda LA; Giammona AM; Raimondi JC; Fassi JC
    Acta Gastroenterol Latinoam; 1996; 26(2):79-83. PubMed ID: 9137661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
    Behzad-Behbahani A; Mojiri A; Tabei SZ; Farhadi-Andarabi A; Pouransari R; Yaghobi R; Rahsaz M; Banihashemi M; Malek-Hosseini SA; Javid A; Bahador A; Reisjalali A; Behzadi S; Salehipour M; Salahl A; Davari R; Janghorban P; Torb A; Salah AR
    Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of Renal Transplant From Deceased Anti-hepatitis C Virus Donors, Poland 1998-2012.
    Pliszczyński J; Jasztal K; Jóźwik A; Kosieradzki M; Danielewicz R; Małkowski P; Czerwiński J
    Transplant Proc; 2018; 50(6):1691-1696. PubMed ID: 30056883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplantation of kidneys from HCV-positive donors: a safe strategy?
    Fabrizi F; Bunnapradist S; Lunghi G; Martin P
    J Nephrol; 2003; 16(5):617-25. PubMed ID: 14733406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor hepatitis C virus status does not adversely affect short-term outcomes in HCV+ recipients in renal transplantation.
    Ali MK; Light JA; Barhyte DY; Sasaki TM; Currier CB; Grandas O; Fowlkes D
    Transplantation; 1998 Dec; 66(12):1694-7. PubMed ID: 9884261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.